
🥩Fabíola C. A., RDMS, RVT🥩
1.7K posts

🥩Fabíola C. A., RDMS, RVT🥩
@FabiolaRDMS
Sonographer, Low Carb/Keto Lover, Meat heals! 🇧🇷🇺🇲




‘hunger is a conditioned response. We have learned through countless repetition that we eat three times a day, based on the time, no matter how hungry we are, and our hunger rises according to match’





Timely editorial by @TheLancetEndo highlights urgent need for policies on ultra-processed foods (UPFs). In this correspondence @CMonteiro_USP and me agree, adding that policies targeting ultra-processed diets as a whole are both realistic and urgent—especially in regions not yet dominated by them—to protect healthy diets & local agri-food systems thelancet.com/journals/landi…







It can be done. Drug free remission of #T2D from @lowcarbGP . Available to everyone, if they ask the correct question. Can it work for me?



What if everything we thought we knew about cholesterol and heart disease risk… doesn’t apply to everyone? In this episode, world-renowned cardiologist Dr. Matthew Budoff unpacks the results of a landmark one-year study tracking 100 lean, metabolically healthy individuals on a ketogenic diet with extremely elevated LDL levels. Dr. Budoff is the Program Director, Director of Cardiac CT, and the endowed chair of preventive cardiology at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. In this interview, Dr. Scher and Dr. Budoff further break down the results of his new publication, which used advanced imaging to demonstrate that LDL cholesterol and ApoB levels are not associated with plaque progression in Lean-Mass Hyper Responders following a #ketogenicdiet. 📊 Surprising insights: • Elevated LDL and ApoB did not predict plaque progression • Some participants with LDLs over 500 showed no plaque at all • A few participants even experienced plaque regression • Existing plaque—not LDL-C or ApoB—did predict plaque accumulation in this population Dr. Budoff explains what these results mean for clinicians, for patients using ketogenic therapy as a medical intervention, and for the broader conversation around cardiovascular disease risk. “It is important that clinicians, along with the general public, are made aware that personalized, data-driven approaches to assessing risk should be considered based on individual conditions,” said Dr. Budoff. “The existence of this phenotype suggests that alternative markers or tests should be used to establish metabolic health in some cases.” 🎬 These exciting new findings are featured in Dave Feldman and Jen Isenhart’s upcoming documentary, The Cholesterol Code, the story of how a software engineer conducts a groundbreaking study on an unusual group of people—lean, healthy individuals whose doctors are convinced they’ll die young. Real stories of healing with ketogenic diets provide a blueprint for using food as powerful medicine. Visit cholesterolcodemovie.com to learn more about the film and to be the first to hear about private screenings and the general release in the fall. Expert Featured: Dr. Matthew Budoff @BudoffMd lundquist.org/matthew-budoff… Resources Mentioned: Plaque Begets Plaque, ApoB Does Not jacc.org/doi/10.1016/j.… Diagnostic and Preventative Cardiovascular Imaging Center calciumscan.com CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope mycme.com/courses/managi… Brain Energy: The Metabolic Theory of Mental Illness mycme.com/courses/brain-… Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org






